---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-001891"
form_type: "8-K"
ticker: "NHC"
cik: "0001047335"
company_name: "NATIONAL HEALTHCARE CORP"
filed_at: "2022-01-28T23:59:59+00:00"
generated_at: "2026-06-27T13:58:52.085828+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# National Healthcare appoints Sandra Y. Trail to Board of Directors, effective Feb 1, 2022

## Summary
- Board increased from 7 to 8 directors; Ms. Trail appointed effective Feb 1, 2022.
- Ms. Trail is an attorney and CPA with 35+ years experience; principal at Trail, Coleman and Stearns.
- She is deemed independent; will receive standard non-employee director compensation.
- Ms. Trail will be a nominee for a 3-year term at the 2022 Annual Meeting.

## SEC filing metadata
- accession: 0001437749-22-001891
- form_type: 8-K
- ticker: NHC
- cik: 0001047335
- company_name: NATIONAL HEALTHCARE CORP
- filed_at: 2022-01-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1047335/000143774922001891/0001437749-22-001891-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1047335/000143774922001891/nhc20220114_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-001891
- JSON: https://secwatch.observer/filing/0001437749-22-001891.json
- Plain text: https://secwatch.observer/filing/0001437749-22-001891.txt

## Key facts
- Executive change
  Sandra Y. Trail was appointed as Director at NATIONAL HEALTHCARE CORP.
  - Action: appointed
  - Role: Director
  source text: appointed Ms. Sandra Y. Trail to fill the resulting vacancy as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1047335/000143774922001891/0001437749-22-001891-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.